CompaniesBioSim Pharmaceuticals

BioSim Pharmaceuticals

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (4)
View all

Total Trials

4

As Lead Sponsor

0

As Collaborator

4

Total Enrollment

5,250

By Phase

EARLY_PHASE1: 2PHASE3: 1PHASE1/PHASE2: 1

By Status

UNKNOWN: 3RECRUITING: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
Today
NCT05226429
NCT05508477
NCT05918939
NCT06259578
Hover over trial bars to see details

Recent Trials

NCT06259578Collaborator
UNAIR Inactivated COVID-19 Vaccine as Homologue Booster (Immunobridging Study)
EARLY_PHASE1Recruiting
400 participants
Started: Jan 29, 2024 · Completed: Dec 29, 2024
NCT05918939Collaborator
UNAIR Inactivated COVID-19 Vaccine as Heterologue Booster (Immunobridging Study)
EARLY_PHASE1Unknown
350 participants
Started: Sep 5, 2022 · Completed: Sep 5, 2023
NCT05508477Collaborator
UNAIR Inactivated COVID-19 Vaccine Phase III (Immunobridging Study)
PHASE3Unknown
4,005 participants
Started: Jun 28, 2022 · Completed: May 28, 2023
NCT05226429Collaborator
UNAIR Inactivated COVID-19 Vaccine
PHASE1/PHASE2Unknown
495 participants
Started: Feb 8, 2022 · Completed: Jul 6, 2023